[Case of polycystic lung disease with mixed infections due to Aspergillus and Mycobacterium fortuitum successfully treated by AZM].
Ito
Nagayoshi
N
Kudo
Shoji
S
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000935:Antifungal Agents / Q000008:administration & dosage; D001228:Aspergillosis / Q000188:drug therapy* / Q000382:microbiology*; D001232:Aspergillus fumigatus; D017963:Azithromycin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003560:Cysts / Q000188:drug therapy* / Q000382:microbiology*; D004359:Drug Therapy, Combination; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000493:pharmacokinetics; D008172:Lung Diseases, Fungal / Q000188:drug therapy* / Q000382:microbiology*; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy* / Q000382:microbiology*; D019907:Mycobacterium fortuitum; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D017963:Azithromycin